
    
      Subjects with mild allergic asthma are examined before, immediately after and 2 months after
      a course of treatment with anti-IgE. The following are examined: Allergen skin tests,
      allergen induced asthma, peripheral blood basophils, pulmonary bronchial mucosal mast cells.
    
  